Here are five highlights:
1. Misonix’s net sales for the second quarter 2016 reached $6 million, compared to $5.6 million for the same period last year.
2. The BoneScalpel global revenue increased 8 percent to $3.2 million, and U.S. revenue increased 13 percent to $1.9 million.
3. In the United States, the company sold 35 BoneScalpel units in the second quarter, compared to 27 in the same period last year.
4. SonicOneOR global revenue increased 64 percent to $745,000 in the second quarter.
5. Recurring revenue of BoneScalpel, SonaStar and SonicOne disposable sales increased to $3.8 million.
More articles on devices:
Spine surgery reimbursement: Key thoughts on coverage for new technology
Stryker buys Synergetics’ neuro portfolio on the heels of Sage acquisition: 5 key notes
NuVasive establishes new 52-week low: 4 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
